1. Ministry of Health and Welfare. Cancer Control Act, 2003 [Internet]. Seoul (KR): Korea Ministry of Government Legislation, c2012 [cited 2012 Nov 8]. Available from:
http://www.law.go.kr/main.html
2. Cho B, Lee CM. Current situation of national health screening systems in Korea. J Korean Med Assoc 2011;54:666–669.
3. Lee EH, Han MA, Lee HY, Jun JK, Choi KS, Park EC. Liver cancer screening in Korea: a report on the 2008 National Cancer Screening Programme. Asian Pac J Cancer Prev 2010;11:1305–1310.
4. Lee YY, Oh DK, Choi KS, Jung KW, Lee HY, Jun JK. The current status of gastric cancer screening in Korea: report on the National Cancer Screening Programme, 2009. Asian Pac J Cancer Prev 2011;12:3495–3500.
6. National Health Insurance Cooperation. Current Status of Healthcare Institutions Participating National Cancer Screening Program, 2011 [Personal communication].
10. Korean Liver Cancer Study Group and National Cancer Center, Korea. Practice guidelines for management of hepatocellular carcinoma 2009. Korean J Hepatol 2009;15:391–423.
11. Song IH, Kim KS. Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol 2009;15((Suppl 6)):S50–S59.
12. Park KW, Park JW, Choi JI, et al. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. J Gastroenterol Hepatol 2008;23:467–473.
13. Ministry of Health and Welfare. Guideline of National Cancer Screening Program 2011. Seoul: Ministry of Health and Welfare, 2011.
15. The Korea Centers for Disease Control and Prevention. The 4th Korea National Health and Nutrition Examination Survey (2007-2009) [Internet]. Osong (KR): The Korea Centers for Disease Control and Prevention, c2012 [cited 2012 Sep 06]. Available from:
http://knhanes.cdc.go.kr/knhanes/index.do
16. Sherman M, Bruix J, Porayko M, Tran T; AASLD Practice Guidelines Committee. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations. Hepatology 2012;56:793–796.
18. Singal A, Volk ML, Waljee A, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther 2009;30:37–47.
19. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alphafetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006;101:513–523.
20. Trinchet JC, Chaffaut C, Bourcier V, et al. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities. Hepatology 2011;54:1987–1997.
21. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908–943.
23. Singal AG, Conjeevaram HS, Volk ML, et al. Effectiveness of hepatocellular carcinoma surveillance in patients with cirrhosis. Cancer Epidemiol Biomarkers Prev 2012;21:793–799.